Copyright
©The Author(s) 2025.
World J Virol. Jun 25, 2025; 14(2): 101976
Published online Jun 25, 2025. doi: 10.5501/wjv.v14.i2.101976
Published online Jun 25, 2025. doi: 10.5501/wjv.v14.i2.101976
Table 4 Area under the curve, Sensitivity, specificity and Youden index for upregulated miRNAs
HCV groups | Micro RNAs | AUC | Sensitivity | Specificity | Youden Index |
Mild | miR-122 | 0.646 | 79.5% | 40.8% | 0.203 |
miR-155 | 0.607 | 70.2% | 44.9% | 0.151 | |
miR-21 | 0.518 | 98% | 24.5% | 0.225 | |
Moderate | miR-122 | 0.774 | 92% | 62.9% | 0.549 |
miR-155 | 0.898 | 96% | 76% | 0.720 | |
miR-21 | 0.826 | 96% | 72.6% | 0.686 | |
Severe | miR-122 | 0.979 | 96.2% | 89.1% | 0.852 |
miR-155 | 0.896 | 88.5% | 79.9% | 0.683 | |
miR-21 | 0.969 | 92.3% | 87.9% | 0.802 |
- Citation: Kaur N, Garg R, Tapasvi C, Goyal G. Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients. World J Virol 2025; 14(2): 101976
- URL: https://www.wjgnet.com/2220-3249/full/v14/i2/101976.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i2.101976